4th Quarter - Report

ALLERGAN USA, INC. for ALLERGAN USA, INC.

Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Supporting proposals to strengthen safety standards and enforcement of the Drug Quality and Security Act.

LobbyistCovered position, as disclosed
DANIEL M HARDER —
ROBERT W. LIVELY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Advocacy of Allergans Social Contract with Patients to encourage greater access to critical innovative medicines; support for strategic, market-based international trade policies to improve patient access and intellectual property protections of life-saving medical therapies.

LobbyistCovered position, as disclosed
DANIEL M HARDER —
ROBERT W. LIVELY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Proposals to maintain and strengthen patient access to needed prescription medicine and medical devices under the Medicare and Medicaid programs.

LobbyistCovered position, as disclosed
DANIEL M HARDER —
ROBERT W. LIVELY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Proposals to enhance intellectual property protections to meet unmet medical needs, notably research and development of life-saving therapies; proposals to modify the Food, Drug and Cosmetic Act which simplify pathways to approve patent claims.

LobbyistCovered position, as disclosed
DANIEL M HARDER —
ROBERT W. LIVELY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Encouraging proposals to improve access and coverage of appropriate mental health care treatment for all patients in need; proposals to encourage investments into research and development of novel treatments for diseases to improve patients' quality of life; supporting protections for patients from illegal and inappropriate exposure to counterfeit and diverted medicines.

LobbyistCovered position, as disclosed
DANIEL M HARDER —
ROBERT W. LIVELY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.